Tianmu Pharmaceutical Company: Notice of Approval for Re-registration of Subsidiary's Drugs

Tianmu Pharmaceutical announced that its subsidiaries, Huangshan Tianmu Pharmaceutical Co., Ltd. and Huangshan Tianmu Menthol Pharmaceutical Co., Ltd., have received the "Drug Re-registration Approval Notice" issued by the Anhui Provincial Drug Administration. The drugs approved this time include kidney-tonifying tablets, Panax notoginseng capsules, cold relief tablets, fever reducing granules, Monkey Head Mushroom tablets, Ligusticum Chuanxiong tablets, Lonicera japonica detoxification tablets, Antelope cold tablets, Brain Life tablets, Mulberry Chrysanthemum cold tablets, Polygonum multiflorum longevity tablets, and Blood-nourishing and calming tablets. The approval notice for these drugs is valid until 2030 and is applicable to symptoms such as backache and weakness in the legs, dizziness, and tinnitus. This move will have a positive impact on the company's future production, sales, and promotion.